Mental Health Tech: The $5.5B Market Opportunity | LeverVenture

The binding constraint on mental health technology was never demand. Unmet need is large, visible, and well documented across every payer type. The constraint is who pays, on what terms, and whether that payer keeps paying after the first year. A company can sign millions of covered lives and still fail, because a covered life is not revenue — a covered life is a benefit that has to be used, billed correctly, and renewed by a buyer who wants proof it worked.

That reframes the opportunity. The interesting question for a growth equity investor is not the size of the addressable population. It is which of the three distinct buyer channels a company sells into, what that channel demands as proof of value, and whether the company's retention curve can survive contact with a renewal conversation eighteen months in. Market structure, not market size, is what determines which businesses in this category compound and which ones plateau at their first big enterprise logo.

01Three Channels, Three Different Buyers

Employer and EAP channels buy on utilization and workforce outcomes, with a purchasing cycle set by open enrollment and a benefits consultant in the room. Health plan and payer channels buy on medical cost offset and require claims-level integration, credentialing, and often a value-based contract structure. Direct-to-consumer buys on acquisition cost and monthly retention, with no employer or plan absorbing churn on the company's behalf. These are not variations on one go-to-market motion. They are three different businesses wearing the same product.

02Measurement-Based Care Is Becoming the Underwriting Standard

Payers increasingly want to see symptom tracking over time, not a description of the modality. Standardized instruments such as the PHQ-9 for depression and the GAD-7 for anxiety, administered at intake and on a defined cadence, give a health plan or employer something closer to a clinical outcome than a satisfaction score. Companies that have built measurement into the product from day one — not bolted on as a reporting layer for a renewal deck — have an easier time in payer diligence, because the data was generated as a byproduct of care rather than assembled after the fact to answer a question a buyer asked.

This has a second-order effect worth underwriting for directly: measurement-based care data is also what lets a company defend its price against a self-insured employer's finance team, which will otherwise default to treating behavioral health as a discretionary line item to cut in a budget cycle.

03The Collaborative Care Model Shows What Payer-Aligned Looks Like

Medicare's Psychiatric Collaborative Care Model, billed under CPT codes 99492 through 99494 and HCPCS code G2214, pays a primary care practice for behavioral health care management delivered in consultation with a psychiatric consultant, tracked against measurement-based outcomes. It is instructive not because every company should replicate it, but because it shows what a payer-native product looks like when the billing codes, the outcome measurement, and the care team roles are designed together rather than layered on afterward. Companies building for payer and health-system channels increasingly design toward existing reimbursement codes like these rather than hoping a novel billing arrangement gets negotiated deal by deal. That difference — designed for the code that already exists, versus hoping to invent a new one — shows up directly in time-to-revenue.

04Engagement Decay Is the Real Unit Economics Problem

The number that should worry a diligence team more than customer acquisition cost is the engagement decay curve: the rate at which active users of a direct-to-consumer mental health product stop opening the app. Consumer mental health products commonly show steep drop-off within the first sixty to ninety days, the same pattern seen across most consumer wellness categories, and unlike a fitness app, a lapsed user of a mental health product is not merely lost revenue — it can represent unmet clinical need the company can no longer see. A subscription model priced against month-one engagement and sold against month-one retention economics is underwriting a number that will not hold.

A covered life is a benefit that has to be used, billed correctly, and renewed by a buyer who wants proof it worked — not a customer, and not revenue.

This is exactly where the payer and employer channels behave differently from direct-to-consumer, and why the distinction matters more than the aggregate market figure any single company puts in a deck. An employer-sold product with a low utilization rate still renews if the employer believes the benefit is table stakes competitively; a plan-sold product with a low outcome signal does not renew regardless of utilization; a consumer-sold product with declining engagement loses the customer entirely, with no institutional buyer standing between the company and the churn.

05What to Underwrite

Ask which of the three channels actually generates the revenue in the data room, not which channel the pitch leads with — companies frequently emphasize a payer logo while the revenue is still predominantly consumer. Ask for the engagement curve past day ninety, not day seven. Ask whether the measurement data was built into care delivery or assembled for the deck. And ask how the company's pricing model would need to change if reimbursement, not subscription revenue, became the primary payer over the next contract cycle.

A useful diligence exercise is to model what happens to the company's revenue if the direct-to-consumer channel were removed entirely. A company whose payer and employer contracts alone would sustain the business has a structurally different risk profile than one whose enterprise logos are a credibility layer sitting on top of a consumer subscription engine. The former is underwriting a services business with a long sales cycle and durable renewals. The latter is underwriting a consumer app with a mental-health veneer, and the churn math for consumer apps applies whether or not the product treats a clinical condition. The supply side of this market — whether there is enough clinical capacity to deliver on what gets sold — is a distinct question with its own economics, addressed in our companion analysis of mental health access and workforce capacity. The two arguments are deliberately separate: this piece is about who pays and whether they keep paying; that one is about whether there is enough clinician capacity to deliver the care being sold. Retention economics in adjacent categories follow a similar logic, discussed in our note on SaaS metrics beyond the Rule of 40, and the broader thesis connecting outcomes to returns is laid out in our ROI² framework.

06Frequently asked questions

What are the three main ways mental health technology companies get paid?

Employer and EAP channels buy on utilization and workforce outcomes, decided by a benefits leader on an annual cycle tied to open enrollment. Health plan and payer channels buy on medical cost offset, requiring claims-level integration and 12 to 18 months of credentialing. Direct-to-consumer sells on acquisition cost and monthly retention, with no employer or plan absorbing churn.

Why doesn't a large number of covered lives guarantee revenue for a mental health app?

A covered life is a benefit that has to be used, billed correctly, and renewed by a buyer who wants proof it worked—it is not revenue by itself. A company can sign millions of covered lives and still fail if utilization, billing accuracy, or renewal proof falls short of what the buyer requires.

What is measurement-based care, and why do payers want to see it?

Measurement-based care means tracking symptoms over time using standardized instruments such as the PHQ-9 for depression and the GAD-7 for anxiety, given at intake and on a defined cadence. Payers increasingly want this data because it looks closer to a clinical outcome than a satisfaction score, and it helps defend pricing at renewal.

What is Medicare's Psychiatric Collaborative Care Model?

It is a Medicare program, billed under CPT codes 99492 through 99494 and HCPCS code G2214, that pays a primary care practice for behavioral health care management delivered with a psychiatric consultant, tracked against measurement-based outcomes. It shows what a payer-native product looks like when billing, outcomes, and care team roles are designed together.

Why does engagement decay matter more than customer acquisition cost for consumer mental health apps?

Consumer mental health products commonly show steep drop-off within the first sixty to ninety days. Unlike a fitness app, a lapsed mental-health user is not just lost revenue—it can represent unmet clinical need the company can no longer see, which undermines a subscription model priced against month-one engagement.

What should a diligence team ask about a mental health tech company's revenue mix?

Ask which of the three channels—employer, payer, or direct-to-consumer—actually generates the revenue in the data room, not which channel the pitch leads with. Also ask for the engagement curve past day ninety, not day seven, and whether the measurement data was built into care delivery or assembled for the deck.

Nothing in this piece is investment, legal, tax or accounting advice, and nothing in it is an offer to sell or a solicitation of an offer to buy any security.